Novel miRNA Targets and Therapies in the Triple-Negative Breast Cancer Microenvironment: An Emerging Hope for a Challenging Disease

Treatment of triple-negative breast cancer (TNBC) remains challenging because of the heterogeneity of the disease and lack of single targetable driving mutations. TNBC does not rely on estrogen, progesterone or epidermal growth factor receptors and is associated with aggressive disease progression a...

Descripción completa

Detalles Bibliográficos
Autor principal: Qattan, Amal
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7727826/
https://www.ncbi.nlm.nih.gov/pubmed/33255471
http://dx.doi.org/10.3390/ijms21238905

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7727826/
https://www.ncbi.nlm.nih.gov/pubmed/33255471
http://dx.doi.org/10.3390/ijms21238905

Ejemplares similares